Sign in to continue:

Wednesday, April 1st, 2026

Tilray Brands 2025 Financial Results: Revenue Breakdown, Business Segment Performance, and Year-over-Year Changes





Tilray Brands, Inc. Q3 2026 Financial Report Analysis

Tilray Brands, Inc. Issues Q3 2026 Financial Results: Key Highlights for Investors

Summary of Report and Key Points

  • Tilray Brands, Inc. (NASDAQ: TLRY) released its Q3 2026 financial results on April 1, 2026 via Form 8-K.
  • The company maintains a strong balance sheet with cash, restricted cash, and marketable securities totaling \$264.8 million at quarter-end, enabling flexibility for strategic investments and opportunities.
  • Net (Debt) Cash Position: Tilray reported a net cash position of \$3.5 million, marking a significant improvement of \$40.2 million from a net debt position of \$36.6 million in the prior year period.
  • Debt Reduction: The company further reduced its total outstanding debt by \$4.2 million during the quarter.
  • Project 420 Synergy Program: Successfully completed in the quarter, delivering approximately \$33 million in annualized cost savings and meaningful operational efficiencies.
  • Reverse Stock Split: Current and prior year share amounts have been retrospectively adjusted to reflect the Reverse Stock Split, effective December 2, 2025. This is a significant corporate action and could affect investor perception and share liquidity.
  • Non-GAAP Measures: Tilray continues to use and report several non-GAAP metrics including Adjusted EBITDA, Adjusted gross margin/profit, Adjusted net income/loss, free cash flow, and constant currency presentations. Management believes these provide useful additional information for investors, but cautions they should not be considered in isolation.

Financial Statements & Results

Consolidated Financial Position

  • Total assets: \$2,074,327,000 as of February 28, 2026
  • Total liabilities and stockholders’ equity: \$2,074,722,000 as of February 28, 2026
  • Common stock: 116,549,939 shares issued and outstanding after the reverse split
  • Additional paid-in capital: \$6,520,501,000
  • Stockholders’ equity: \$1,557,368,000 (Tilray shareholders), \$1,525,607,000 (total including non-controlling interests)

Income and Comprehensive Income

  • Gross profit: \$54,954,000 for the three months ended February 28, 2026
  • Net loss attributable to Tilray shareholders: \$(26,572,000) for three months, \$(789,436,000) for nine months
  • Net loss per share (basic and diluted): \$(0.24) for the three months ended February 28, 2026
  • Weighted average shares outstanding (basic): 112,675,734

Cash Flow Highlights

  • Net cash used in operating activities: \$(61,000,000)
  • Net cash used in investing activities: \$(4,621,000)
  • Net cash used in financing activities: \$(54,044,000)
  • Net increase in cash and cash equivalents: \$27,839,000

Important Shareholder Information & Price-Sensitive Items

  • Reverse Stock Split: This action, effective December 2, 2025, will impact both the share count and price per share, and is critical for shareholders to understand regarding dilution, liquidity, and potential index eligibility.
  • Debt Reduction and Improved Liquidity: Continued reduction in debt and improvement in net cash position signals healthier financial stability, which could positively impact investor confidence and share valuation.
  • Completion of Project 420: \$33 million in annualized cost savings may enhance future profitability and margins. This operational efficiency is a key catalyst for share price movement.
  • Use of Non-GAAP Measures: Investors should take note of the company’s reliance on non-GAAP reporting, which may differ from other companies and could affect comparability. The company warns that forward-looking non-GAAP metrics are not reconciled to GAAP due to unpredictability of certain items (e.g., litigation, FX, impairments).
  • Forward-Looking Statements: The company’s outlook includes intentions to become a leading lifestyle CPG and beverage alcohol company, achieve long-term profitability, invest in AI strategies, and pursue U.S. cannabis legalization/rescheduling. These statements, while promising, are subject to risks and uncertainties.
  • Reduced Operating Cash Flow: Net cash used in operating activities is substantial, which may indicate ongoing challenges in core operations.
  • Share Capital Issuance: \$73 million of share capital issued, net of cash issuance costs, may dilute existing shareholders but also strengthens the balance sheet.

Other Noteworthy Items

  • Contact Information: Investors can reach Tilray Investor Relations at [email protected] and Media Relations at [email protected].
  • Trading Symbol: TLRY on NASDAQ Global Select Market.
  • Emerging Growth Company Status: Tilray is not an emerging growth company, and has not elected to use extended transition periods for new accounting standards.

Potential Share Price Movers

  • Operational Improvements: The completion of Project 420 and debt reduction are positive catalysts.
  • Reverse Stock Split: May affect share price and liquidity.
  • Strong liquidity position: Enables strategic investments and potential acquisitions.
  • Continued operating losses: May be a concern for investors and could pressure share price if not reversed in coming quarters.

Conclusion

Tilray Brands, Inc.’s Q3 2026 financial results show continued focus on operational efficiencies, debt reduction, and strategic liquidity management. While the completion of Project 420 and a stronger cash position are positives, ongoing net losses and significant cash outflows from operations remain risks. The reverse stock split and share issuance are material corporate actions that investors must consider in their valuation and portfolio decisions. Forward-looking strategies around AI, U.S. cannabis legalization, and beverage/CPG expansion offer potential, but investors should monitor execution and regulatory developments closely.


Disclaimer: This article is for informational purposes only and does not constitute investment advice. Forward-looking statements are subject to risks and uncertainties. Investors should review Tilray’s SEC filings and consult their own advisors before making investment decisions.




View Tilray Brands, Inc. Historical chart here



Teleflex Incorporated 2025 Annual Report: Business Overview, Segments, Products, and Regulatory Compliance

Teleflex Incorporated 2025 Annual Report – Key Highlights fo...

Incannex Healthcare Regains Nasdaq Compliance and Advances Clinical Pipeline with Strong Cash Position

Incannex Healthcare Regains Nasdaq Compliance: Key Milestone...

Star Equity Holdings, Inc. Form 8-K Filing Details, Stock Information, and XBRL Data (February 27, 2026)

Star Equity Holdings, Inc. Files Form 8-K: Material Agreemen...

   Ad